ACM Global Central Laboratory Establishes Mumbai-based Subsidiary to Strengthen Lab Services in India
ACM Global Central Lab has advanced its hybrid central lab model in Mumbai with a state-of-the art operational facility dedicated to manage clinical trials testing in India and provide study support throughout Asia Pacific. Working in conjunction with the largest diagnostic lab in the region, ACM Global oversees the full complement of study support to keep clinical trials on schedule and on budget, including kit building, shipping logistics, projectmanagement, data management, and site support.
“We have been able to build a local team that thoroughly understands the nuances of the market, plus the systems and process at ACM Global to maintain our high global standard for global clinical trial testing,” said Nandan Rao, director, India and general manager, Asia Pacific at ACM Global Central Lab.
ACM Global first established an operational footprint in India seven years ago, and established its hybrid lab model three years ago to support increased activity in the Asia Pacific region. This has enabled ACM Global to take advantage of an established, regional central lab while benefitting from its own advanced data management systems for the centralization and harmonization of test data. With a local staff, data is integrated immediately with the centralized database, and shipping and logistics are navigated at the local level, which means tighter specimen controls and lower total costs to the sponsor.
All studies conducted by the CAP-certified lab are assured precise analytical data managed from a central location with one harmonized database
.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
